Flow cytometric analysis of CD140b transfected 293F stained with Alexa Fluor® 647 Mouse IgG2a, k Isotype Control (left panel) or SDT Alexa Fluor® 647 Mouse Anti-Human CD140b Antibody (right panel) at 5 μl/test. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD140b |
| Location | Cell membrane |
| Accession | P09619 |
| Clone Number | S-3078 |
| Antibody Type | Mouse mAb |
| Isotype | IgG2a,k |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | CD140b transfected 293F |
| Purification | Protein A |
| Concentration | 0.2 mg/ml |
| Conjugation | Alexa Fluor® 647 |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 1% BSA, 0.09% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD140b, also known as Platelet-Derived Growth Factor Receptor Beta (PDGFR-β), is a transmembrane receptor tyrosine kinase encoded by the PDGFRB gene in humans, playing a pivotal role in regulating cell proliferation, migration, survival, and differentiation, particularly within mesenchymal lineages such as vascular smooth muscle cells, pericytes, and fibroblasts. Structurally, it consists of an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular tyrosine kinase domain that becomes activated upon binding to specific dimeric isoforms of platelet-derived growth factor (primarily PDGF-BB and PDGF-DD), triggering autophosphorylation and the subsequent recruitment of downstream signaling molecules involved pathways like PI3K/AKT, RAS/MAPK, and PLCγ. This receptor is essential for normal embryonic development, especially in the formation of the cardiovascular system and kidney, while its dysregulation or overexpression is strongly implicated in various pathological conditions, including atherosclerosis, pulmonary hypertension, fibrotic diseases, and certain malignancies such as gliomas and chronic myelomonocytic leukemia, making it a significant therapeutic target for tyrosine kinase inhibitors like imatinib.
Picture
Picture
FC
